Details of issuance or disposal
20th Series of Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause)
Shares delivered since the beginning of the month: 1,000,000 shares (new shares); treasury shares transferred: 0 shares. New shares issued upon exercise during the month: 1,000,000 shares; treasury shares transferred: 0 shares
Exercise ratio: 1.69% (monthly exercise ratio relative to the total number issued). Exercise ratio relating to exercise restrictions: 0.38%
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | 20th Series of Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause) |
| Number of shares to be issued or disposed of | Shares delivered since the beginning of the month: 1,000,000 shares (new shares); treasury shares transferred: 0 shares. New shares issued upon exercise during the month: 1,000,000 shares; treasury shares transferred: 0 shares |
| Dilution Rate | Exercise ratio: 1.69% (monthly exercise ratio relative to the total number issued). Exercise ratio relating to exercise restrictions: 0.38% |
| Total number of issued shares | 278,917,319 shares (as of the end of the month preceding the period covered) → 279,917,319 shares (calculated after the delivery of 1,000,000 new shares) |
| Exercise price | Exercise prices during the month: ¥25.65, ¥26.60 or ¥27.55. Whether an adjustment clause applies and the adjustment floor: Not disclosed |
| Number of Stock Acquisition Rights | Total number issued: Not disclosed. Unexercised as of the end of the preceding month: 456,999; unexercised as of the current date: 446,999 |
| Procedures under the Corporate Code of Conduct | The status of exercise restrictions is stated as the status of compliance with the exercise deadline under Article 434 of the Listing Regulations. |
| Most recent equity financing | Timing 23 December 2025 / Type 20th Series of Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause) / Amount Not disclosed |
Items this document does not state (20)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status in May 2026 of the 20th Series of Stock Acquisition Rights issued on 23 December 2025.